Evidence map›Paper›PMID 36293105›Full record

ArticleInternational journal of molecular sciences2022

miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs.

Gloria Ravegnini, Margherita Nannini, Valentina Indio, Cesar Serrano, Francesca Gorini, Annalisa Astolfi, Aldo Di Vito, Fabiana Morroni, Maria Abbondanza Pantaleo, Patrizia Hrelia and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal transduction and targeted therapy · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Gloria RavegniniDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-7774-402X
Margherita NanniniDepartment of Specialized, Experimental and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.ORCID 0000-0002-2103-1960
Valentina IndioDepartment of Veterinary Medical Sciences, University of Bologna, 40164 Ozzano, Italy.ORCID 0000-0002-8854-3821
Cesar SerranoSarcoma Translational Research Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, C/ Natzaret 115-117, 08035 Barcelona, Spain.
Francesca GoriniDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
Annalisa AstolfiDepartment of Specialized, Experimental and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.ORCID 0000-0002-2732-0747
Aldo Di VitoDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
Fabiana MorroniDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0001-6494-5968
Maria Abbondanza PantaleoDepartment of Specialized, Experimental and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Patrizia HreliaDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-8415-3711
Sabrina AngeliniDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-1609-0421
University of Bologna · ITIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITVall d'Hebron Hospital Universitari · ES

Funding

University of Bologna
6 · The paper itself

Abstract

Gastrointestinal stromal tumors (GISTs) harboring mutations in the

Indexed as

Gastrointestinal Stromal TumorsMicroRNAsHumansImatinib MesylateImmunologic FactorsImmunotherapyMutationProto-Oncogene Proteins c-kitReceptor, Platelet-Derived Growth Factor alphaReceptor Protein-Tyrosine KinasesRNA, MessengerImatinib MesylateImmunologic FactorsMicroRNAsProto-Oncogene Proteins c-kitReceptor, Platelet-Derived Growth Factor alphaReceptor Protein-Tyrosine KinasesRNA, MessengerD842Vgastrointestinal stromal tumorsGISTsmicroRNAsmiRNAsPDGFRA

Identifiers

PMID36293105
PMCPMC9603477
OpenAlexW4306381836

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.